Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Skyhawk, Biogen Expand Alliance in Neurological Disorders | Contract Pharma

What are you searching for?

Sign in
Collaborations & Alliances

Skyhawk, Biogen Expand Alliance in Neurological Disorders

Skyhawk receives an upfront payment and is eligible for future milestones and royalties

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Skyhawk Therapeutics, Inc. has expanded its collaboration with Biogen, extending Biogen’s exclusive license to worldwide rights beyond the original research-stage therapeutic candidates for the treatment of conditions including multiple sclerosis (MS), spinal muscular atrophy (SMA) and additional neurological disorders, leveraging Skyhawk’s SkySTAR technology platform.

Skyhawk receives an upfront payment from Biogen and may receive potential future milestone payments and royalties.

“Biogen is a leading neuro-focused biopharmaceutical company with a compelling history of drug development across a range of challenging conditions,” said Bill Haney, co-founder and chief executive officer of Skyhawk. “Their strong scientific culture has already produced a series of leading global therapeutics and our work together to date has gone very well.  We are excited to expand our opportunity to work together to help more patients with challenging unmet medical needs.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics